Cargando…
Relaxin inhibits renal fibrosis and the epithelial-to-mesenchymal transition via the Wnt/β-catenin signaling pathway
Renal fibrosis is a common characteristic and the final pathological mechanism of chronic kidney disease (CKD). Although CKD remains incurable, inhibition of renal fibrosis is beneficial to inhibit the CKD process. Relaxin alleviates renal fibrosis in some experimental models, but its mechanism rema...
Autores principales: | Feiteng, Chen, Lei, Chen, Deng, Li, Chaoliang, Xu, Zijie, Xu, Yi, Shao, Minglei, Sha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942541/ https://www.ncbi.nlm.nih.gov/pubmed/35311469 http://dx.doi.org/10.1080/0886022X.2022.2044351 |
Ejemplares similares
-
The influence of fasudil on renal proximal tubular cell epithelial–mesenchymal transition induced by parathormone
por: Gao, Ziqing, et al.
Publicado: (2017) -
Effect of 5/6 Nephrectomized Rat Serum on Epithelial-to-Mesenchymal Transition In Vitro
por: Lu, Zhaoyu, et al.
Publicado: (2011) -
A comprehensive analysis of Wnt/β-catenin signaling pathway-related genes and crosstalk pathways in the treatment of As(2)O(3) in renal cancer
por: Li, Yan-Lei, et al.
Publicado: (2018) -
MiR-122-5p promotes peritoneal fibrosis in a rat model of peritoneal dialysis by targeting Smad5 to activate Wnt/β-catenin pathway
por: Liu, Yirong, et al.
Publicado: (2022) -
Relaxin inhibits cardiac fibrosis and endothelial–mesenchymal transition via the Notch pathway
por: Zhou, X, et al.
Publicado: (2015)